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Abstract
© 2016 The Royal Society of Chemistry.The use of scavengers is the most appealing alternative
approach for pre- and post-exposure treatments of nerve agent (NA) poisoning. This can be
achieved either by the use of biocatalysts or artificial enzymes. Administered scavengers act in
the bloodstream by degrading toxic molecules before they reach physiological targets. The first
generation  scavengers  were  stoichiometric  bioscavengers.  Among  them,  human
butyrylcholinesterase has proven to be safe and effective for protection against NA poisoning.
However, stoichiometric neutralization of NAs requires administration of huge doses of costly
biopharmaceuticals.  On  the  other  hand,  catalytic  scavengers  are  capable  of  detoxifying
organophosphorus agents through a turnover mechanism. By virtue of turnover, much lower
doses are needed for rapid neutralization of toxic molecules. Thus, introduction of catalytic
scavengers  will  improve medical  countermeasures  in  terms of  efficacy and cost.  Catalytic
scavengers could also be used as active components in topical skin protectants, functionalized
tissues, and decontaminating gels, foams and lotions. They could also be incorporated into
chemical  protective  suits.  Catalytic  chemical  scavengers  are  artificial  enzymes  such  as
functionalized  cyclodextrins.  Catalytic  bioscavengers  are  enzymes.  Evolved  mutants  of
phosphotriesterases  that  degrade the  most  toxic  NA enantiomers  are  the  most  promising
scavengers. Other engineered enzymes of interest are cholinesterases, carboxylesterases and
prolidases. Operational catalytic bioscavengers must be effective catalysts producible at low
cost,  not  susceptible  to  induced  immune  response  and  iatrogenic  effects,  stable  in  the
bloodstream and upon storage even under field conditions. Gene therapy and artificial enzymes
are still in their infancy, but expectations for these approaches are high for the future of medical
countermeasures.
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